SRPT
Sarepta Therapeutics, Inc.
18.20
1 x 18.24
1 x 18.47
bid
ask
+
0.23
1.28%
19 @ 08:58 AM
18.47 +0.27 (1.48%)
| Ytd | -15.43% | |
| 1y | 2.77% |
17.45
day range
18.41
10.42
52 week range
25.32
| Open | 18.23 | Prev Close | 17.97 | Low | 17.45 | High | 18.41 | Mkt Cap | 1.92B |
| Vol | 3.36M | Avg Vol | 3.17M | EPS | 0.35 | P/E | 52.00 | Forward P/E | 6.68 |
| Beta | 0.20 | Short Ratio | 8.99 | Inst. Own | 99.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 18.09 | 200-d Avg | 19.69 | 1yr Est | 22.00 |
| Income Statement | |||
| Total Revenue | 730.80M | ||
| Revenues (USD) | 730.80M | ||
| Cost of Revenue | 108.77M | ||
| Gross Profit | 622.04M | ||
| Operating Expenses | 263.60M | ||
| Research and Development Expense | 153.96M | ||
| Selling, General and Administrative Expense | 108.95M | ||
| Operating Income | 358.43M | ||
| Income Tax Expense | 12.22M | ||
| Net Income | 330.96M | ||
| Net Income Common Stock | 330.96M | ||
| Net Income Common Stock (USD) | 330.96M | ||
| Consolidated Income | 330.96M | ||
| Earnings per Basic Share | 3.15 | ||
| Earnings per Basic Share (USD) | 3.15 | ||
| Earnings per Diluted Share | 2.88 | ||
| Earning Before Interest & Taxes (EBIT) | 343.17M | ||
| Earning Before Interest & Taxes (USD) | 343.17M | ||
| Weighted Average Shares | 104.99M | ||
| Weighted Average Shares Diluted | 121.92M | ||
| Balance Sheet | |||
| Cash and Equivalents | 464.45M | ||
| Cash and Equivalents (USD) | 464.45M | ||
| Investments | 270.68M | ||
| Investments Current | 188.74M | ||
| Investments Non-Current | 81.94M | ||
| Trade and Non-Trade Receivables | 394.82M | ||
| Current Assets | 2.31B | ||
| Property, Plant & Equipment Net | 460.30M | ||
| Total Assets | 3.18B | ||
| Total Debt | 1.04B | ||
| Current Liabilities | 499.16M | ||
| Debt Non-Current | 1.04B | ||
| Total Liabilities | 1.67B | ||
| Accumulated Retained Earnings (Deficit) | -4.55B | ||
| Accumulated Other Comprehensive Income | -121.00K | ||
| Shareholders Equity | 1.51B | ||
| Shareholders Equity (USD) | 1.51B | ||
| Assets Non-Current | 869.06M | ||
| Total Debt (USD) | 1.04B | ||
| Deferred Revenue | 252.39M | ||
| Inventory | 1.18B | ||
| Liabilities Non-Current | 1.17B | ||
| Trade and Non-Trade Payables | 70.38M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.70M | ||
| Net Cash Flow from Financing | 241.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -336.83M | ||
| Capital Expenditure | -2.08M | ||
| Issuance (Purchase) of Equity Shares | 241.00K | ||
| Net Cash Flow from Investing | -134.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -131.31M | ||
| Net Cash Flow from Operations | -202.68M | ||
| Share Based Compensation | 29.40M | ||